NCT02344875View on ClinicalTrials.gov

Clinical Pharmacology of FYU-981 (Elder Subjects)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy
Interventions
DRUG

FYU-981, (Oral single dosing)

Trial Locations (1)

Unknown

Japan, Tokyo

Sponsors
All Listed Sponsors
lead

Fuji Yakuhin Co., Ltd.

INDUSTRY